Sunday 11 October 2026 Export all DOC data to Excel Powerpack

Healthpeak Properties, Inc.

DOC Real Estate Reit Healthcare Facilities

Healthpeak Properties, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.8 billion, up 4.52% from fiscal 2024. In the quarter to June 2026, revenue grew 11.1%, EPS grew 60.0%, free cash flow fell 30.5% and total debt rose 11.0%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for five consecutive years, operating cash flow growth for five.

18.80 0.28 +1.51%
Market cap
$13.1B
P/E
53.8×
Fwd P/E
71.3×
Dividend yield
8.10%
F-score
4/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
22.22 29.78 12.52 344.70 38.27 38.81 27.35 35.77 57.91 160.80
Piotroski F-Score
6 4 5 5 6 8 5 5 6 4
P/S ratio
6.53 6.57 7.15 9.60 9.89 10.26 6.65 5.02 5.07 3.97
P/FCF ratio
14.29 9.90 6.73 0.00 161.80 17.67 0.00 31.23 12.29 32.98
P/Operating CF
64.56 58.07 61.22 78.79 74.42 86.86 66.23 47.38 48.31 38.06
P/B ratio
2.34 2.17 2.03 2.57 2.23 2.76 1.91 1.59 1.51 1.37
Price to Tangible BV
2.55 2.34 2.13 2.67 2.40 2.97 2.03 1.67 1.68 1.51
EV/Sales
10.79 10.79 10.09 12.91 13.66 13.40 9.74 8.10 8.23 7.26
EV/EBITDA
17.33 21.04 18.49 24.62 28.82 27.79 20.84 16.43 17.34 13.90
EV/Operating CF
18.92 23.55 21.96 27.24 29.62 31.95 22.30 18.47 20.76 16.38
EV/FCF
23.59 16.25 9.49 (19.96) 223.30 23.08 (219.14) 50.35 19.94 60.42
Quick Ratio
0.44 0.31 0.48 0.30 0.20 0.34 0.23 0.34 0.36 0.86
Current Ratio
2.37 1.09 0.64 0.72 0.46 0.90 0.72 0.67 2.56 2.82
Net Debt/EBITDA
6.83 8.23 6.18 6.05 7.94 6.52 6.61 6.24 6.66 6.32
Debt/Assets
58.31% 55.94% 43.78% 42.77% 39.56% 40.44% 41.20% 43.80% 43.72% 48.48%
Debt/Equity
1.55 1.41 0.85 0.90 0.86 0.87 0.90 1.00 0.96 1.21
Asset Turnover
0.11 0.12 0.09 0.09 0.11 0.12 0.13 0.14 0.15 0.14
Operating CF/Net income
1.94 2.05 0.80 19.23 1.84 1.58 1.81 3.14 4.42 17.76
Capex/Depreciation
(0.39) 0.67 1.93 (2.90) (1.05) 0.51 (1.60) (0.93) 0.05 (0.96)
Interest Coverage
1.53 1.25 1.15 1.32 0.70 2.00 1.99 2.11 1.13 1.70
ROE
7.99% 7.16% 17.48% 0.67% 5.89% 7.00% 6.99% 4.33% 3.04% 0.82%
ROA
3.37% 2.77% 7.90% 0.33% 2.75% 3.22% 3.21% 1.93% 1.36% 0.35%
ROIC
2.96% 1.79% 1.57% 1.43% 0.71% 1.51% 1.59% 1.94% 1.12% 1.86%
Return on Tangible Assets
5.27% 3.84% 10.51% 0.54% 3.84% 3.99% 3.89% 2.37% 1.43% 0.41%
Average Days of Receivables
7.73 8.04 14.76 13.20 9.38 9.37 9.46 9.34 10.38 10.13
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
4.87% 4.80% 8.12% 7.50% 5.67% 5.18% 6.36% 4.36% 3.60% 3.20%
Intangible Assets out of Total Assets
0.03 0.03 0.02 0.02 0.03 0.03 0.03 0.02 0.04 0.04
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00% 1.06% 0.96% 1.28% 0.66% 0.58% 0.51%
Graham Net Nets
(0.63) (0.66) (0.45) (0.41) (0.51) (0.39) (0.59) (0.76) (0.66) (0.98)
Graham Number
19.58 15.29 26.28 5.49 15.51 16.56 16.70 12.59 10.27 5.13
Earnings Yield
4.50% 3.36% 7.98% 0.29% 2.61% 2.58% 3.66% 2.80% 1.73% 0.62%
Free Cash Flow Yield
7.00% 10.10% 14.86% (6.74%) 0.62% 5.66% (0.67%) 3.20% 8.14% 3.03%
Revenue per Share
4.56 3.94 2.53 2.55 3.10 3.52 3.83 3.99 4.00 4.06
Operating CF per Share
2.60 1.81 1.80 1.74 1.43 1.48 1.67 1.75 1.58 1.80
Capex per Share
(0.52) 0.81 2.37 (4.11) (1.24) 0.57 (1.84) (1.11) 0.07 (1.31)
Free Cash Flow per Share
2.08 2.62 4.17 (2.37) 0.19 2.04 (0.17) 0.64 1.65 0.49
Cash per Share
0.29 0.18 0.30 0.19 0.21 0.39 0.24 0.31 0.27 0.77
Shareholders Equity per Share
12.72 11.94 13.84 13.71 13.74 13.10 13.33 12.57 13.40 11.70
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
12.72 11.94 13.84 13.71 13.74 13.10 13.33 12.57 13.40 11.70
Free Cash Flow
973.40 1,227.13 1,963.46 (1,154.66) 100.59 1,100.79 (91.62) 350.84 1,114.76 339.32
Working Capital
572.70 34.52 (140.57) (128.33) (411.54) (79.14) (217.38) (213.90) 1,128.50 1,306.14
Capital Expenditures
(240.73) 380.09 1,114.75 (2,000.73) (657.84) 305.54 (991.88) (605.40) 44.27 (912.63)
Net Current Asset Value
(8,827.90) (8,057.26) (5,954.95) (7,036.21) (8,281.06) (7,522.52) (8,033.53) (8,379.51) (9,029.39) (10,168.50)
EV/EBIT
32.38 51.90 43.41 93.36 145.95 80.58 58.24 41.86 70.44 39.47
Capex to Sales
0.11 (0.21) (0.94) 1.61 0.40 (0.16) 0.48 0.28 (0.02) 0.32
Price to Operating Income
19.61 31.61 30.76 69.42 105.75 61.68 39.76 25.96 43.40 21.54
Other line items
Depreciation/Fixed assets
0.05 0.05 0.06 0.08 0.06 0.05 0.05 0.05 0.06 0.06
Cash ROIC
6.38% 9.05% 16.07% (9.05%) 0.73% 8.19% (0.66%) 2.52% 6.21% 1.83%
Accounts Receivable Turnover
45.28 43.06 26.80 26.67 37.77 41.69 40.37 39.92 40.72 36.39
Accounts Payable Turnover
1.74 1.63 0.95 0.95 1.28 1.02 1.13 1.26 1.55 1.56
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
206.31 220.09 377.46 412.10 354.77 356.55 326.72 265.92 246.31 232.27
Days of Inventory on Hand
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Receivables
47.02 42.92 44.45 46.51 43.56 45.48 51.06 54.63 66.32 77.57
Average Payables
424.07 409.55 396.66 424.56 609.07 758.00 763.93 714.84 691.27 721.93
Average Assets
18,604.56 14,923.86 13,403.51 13,375.72 14,976.49 15,588.81 15,514.38 15,735.04 17,818.56 20,137.14
Average Common Equity
7,843.81 5,768.12 6,053.76 6,590.03 6,978.71 7,174.36 7,120.68 7,029.32 7,965.53 8,598.94

Fold the line items

Columns are period end dates